Skip to main content
Premium Trial:

Request an Annual Quote

SciGene, Roche NimbleGen, GE Healthcare

SciGene this week launched its Mai Tai Hybridization System, a new microarray slide hybridization system that incubates four slide microarrays at once.
The Mai Tai System consists of a two-piece cassette that seals up to four Agilent gasket slide microarray assemblies. After loading samples and sealing, cassettes are rotated during incubation using a SciGene Model 777 Microarray Oven that provides “bubble mixing” of the sample.
Up to eight cassettes holding 32 slides can be rotated simultaneously, the company said. The Mai Tai cassette has a microplate footprint for compatibility with robotic liquid handling systems and is sealed after sample loading without the use of tools.

Roche NimbleGen this week launched its NimbleGen Sequence Capture technology for scientists interested in selecting targeted regions of the genome for high-throughput sequencing.
The new technology will initially be offered as a service and enables researchers to easily and rapidly capture up to five million targeted bases from the human or mouse genomes, the company said. Roche NimbleGen plans to make NimbleGen Sequence Capture arrays and related reagents and instruments available in the future.

GE Healthcare last week launched Biacore T100 software version 2. The software is intended for use with the Biacore T100 label-free protein interaction analysis system to enable calibration-free concentration analysis of proteins. Version 2 allows users to measure protein concentration without the need for a standard, GE said.
The new software also reduces time spent on the development of kinetic analysis assays through the single-cycle kinetics function. Additionally, data evaluation has been improved to enable the simultaneous analysis of multiple samples, supported by inbuilt QC functions/tools.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.